Viewing Study NCT00002093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-01-25 @ 12:41 AM
Study NCT ID: NCT00002093
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
Sponsor: Nexstar Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma, Kaposi View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vincristine View
None Sarcoma, Kaposi View
None Liposomes View
None Doxorubicin View
None Acquired Immunodeficiency Syndrome View
None Bleomycin View
None Daunorubicin View
None Drug Carriers View